Rosoxacin

Rosoxacin (tradename Eradacil®) is a quinolone antibiotic indicated for the treatment of urinary tract infections and certain sexually transmitted diseases. Rosoxacin is not available in the United States.

It was developed by Sanofi-Synthelabo (now part of sanofi-aventis).

Template:QuinoloneAntiBiotics

Template:WH Template:WS